I understand the belief that Dr. Dalton may be keeping quiet due to potential plans involving his private ventures merging into $UNVC, but let’s be honest—this speculation has gone on for years with no confirmation, no filings, no progress, and no transparency.

Here’s the reality:
• A public CEO has a fiduciary duty to communicate with shareholders—especially when there’s been zero growth, no revenue for years, and over $14M in payroll liabilities on the books.
• If a merger or material event was truly in the works, the company could file a simple forward-looking statement or placeholder 8K-equivalent on OTC, without revealing non-public details.
• Silence for over 3 years, while the company dilutes by a billion+ shares, with no conference calls, updates, or progress, is not normal—even for OTC Pink.
• The “private company merger” theory has been used since 2020, yet no execution or filings support it.

Belief is not a substitute for corporate governance. If there is truly a strategy at play, Dr. Dalton can—and should—say so, without violating any confidentiality. Until then, shareholders are right to demand transparency.